Physician profile
Talia M Root
NPI 1184624348
$3,338.95
in general payments reported to CMS, 2019-2025
29 companies · $578 in 2025
The $578 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $652 · 2022: $496 · 2023: $1,014 · 2024: $598 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,190.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $740.38 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $562.53 | 2021-2025 | Jardiance, Ofev, Stiolto Respimat |
| Pfizer INC. | $255.73 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $229.40 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Exact Sciences Corporation | $214.46 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $161.71 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $128.56 | 2021-2025 | Veozah |
| Abbvie INC. | $123.85 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $107.12 | 2021-2024 | Eliquis |
| Glaxosmithkline, LLC. | $98.84 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $80.65 | 2021-2025 | Evenity, Prolia, Otezla |
| Daiichi Sankyo INC. | $76.05 | 2021-2023 | Injectafer |
| Amarin Pharma, INC. | $73.57 | 2021 | |
| Edwards Lifesciences Corporation | $71.78 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $70.65 | 2021-2023 | Freestyle Libre 3 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $52.00 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $46.84 | 2022-2024 | Farxiga |
| Nestle Healthcare Nutrition INC. | $35.93 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.77 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $25.14 | 2022 | |
| Sumitomo Pharma America, INC. | $24.47 | 2025 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $20.91 | 2023 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $20.33 | 2024 | Aptima |
| Kyowa Kirin, INC. | $17.77 | 2024 | Crysvita |
| Kowa Pharmaceuticals America, INC. | $16.40 | 2021 | |
| Dexcom, INC. | $15.84 | 2024 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $14.14 | 2022 | |
| Grt US Holding, INC. | $13.18 | 2022 | |
| Esperion Therapeutics, INC. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Talia Root listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.